206 related articles for article (PubMed ID: 22158968)
1. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
Okur MN; Russo A; O'Bryan JP
Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
[TBL] [Abstract][Full Text] [Related]
3. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.
Chandramouli S; Yu CY; Yusoff P; Lao DH; Leong HF; Mizuno K; Guy GR
J Biol Chem; 2008 Jan; 283(3):1679-1691. PubMed ID: 17974561
[TBL] [Abstract][Full Text] [Related]
4. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
[TBL] [Abstract][Full Text] [Related]
5. Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation.
Nikolaienko O; Skrypkina I; Tsyba L; Fedyshyn Y; Morderer D; Buchman V; de la Luna S; Drobot L; Rynditch A
Cell Signal; 2009 May; 21(5):753-9. PubMed ID: 19166927
[TBL] [Abstract][Full Text] [Related]
6. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
7. Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
Lito P; Mets BD; Kleff S; O'Reilly S; Maher VM; McCormick JJ
J Biol Chem; 2008 Jan; 283(4):2002-9. PubMed ID: 18048363
[TBL] [Abstract][Full Text] [Related]
8. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
[TBL] [Abstract][Full Text] [Related]
9. αPIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor.
Kortüm F; Harms FL; Hennighausen N; Rosenberger G
PLoS One; 2015; 10(7):e0132737. PubMed ID: 26177020
[TBL] [Abstract][Full Text] [Related]
10. The LMP2A protein of Epstein-Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases.
Dergai O; Dergai M; Skrypkina I; Matskova L; Tsyba L; Gudkova D; Rynditch A
Cell Signal; 2013 Jan; 25(1):33-40. PubMed ID: 22975684
[TBL] [Abstract][Full Text] [Related]
11. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation.
Lao DH; Yusoff P; Chandramouli S; Philp RJ; Fong CW; Jackson RA; Saw TY; Yu CY; Guy GR
J Biol Chem; 2007 Mar; 282(12):9117-26. PubMed ID: 17255109
[TBL] [Abstract][Full Text] [Related]
12. Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.
Ryan PE; Kales SC; Yadavalli R; Nau MM; Zhang H; Lipkowitz S
PLoS One; 2012; 7(11):e49428. PubMed ID: 23145173
[TBL] [Abstract][Full Text] [Related]
13. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.
Nadeau RJ; Toher JL; Yang X; Kovalenko D; Friesel R
J Cell Biochem; 2007 Jan; 100(1):151-60. PubMed ID: 16888801
[TBL] [Abstract][Full Text] [Related]
15. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
Walsh AM; Lazzara MJ
Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
[TBL] [Abstract][Full Text] [Related]
16. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
17. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.
Wong ES; Fong CW; Lim J; Yusoff P; Low BC; Langdon WY; Guy GR
EMBO J; 2002 Sep; 21(18):4796-808. PubMed ID: 12234920
[TBL] [Abstract][Full Text] [Related]
18. Cbl controls EGFR fate by regulating early endosome fusion.
Visser Smit GD; Place TL; Cole SL; Clausen KA; Vemuganti S; Zhang G; Koland JG; Lill NL
Sci Signal; 2009 Dec; 2(102):ra86. PubMed ID: 20029031
[TBL] [Abstract][Full Text] [Related]
19. Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.
Crotchett BLM; Ceresa BP
Pharmacol Res Perspect; 2021 Apr; 9(2):e00756. PubMed ID: 33811466
[TBL] [Abstract][Full Text] [Related]
20. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
Stern KA; Place TL; Lill NL
Biochem J; 2008 Mar; 410(3):585-94. PubMed ID: 18045238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
